Earnings History Data for IO Biotech, Inc. (IOBT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
IO Biotech, Inc.
IO Biotech Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel, immune-modulating cancer therapies based on its T-win(R) technology platform. IO Biotech Inc. is based in WILMINGTON, Del.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | IOBT | IO Biotech, Inc. | 81.03 | -0.36 | -0.29 | -0.43 | IO Biotech GAAP EPS of -$0.36 misses by $0.09 [11/12/2024 10:16 AM] |
0.9701 | 0.04 (4.60%) |
0.96 | 0.03 (3.21%) |
0.73 - 2.10 | 301,761 | 420,000 | 11,123 | ||
| 13-08-2024 | PM | IOBT | IO Biotech, Inc. | 93.00 | -0.31 | -0.34 | 0.00 | IO Biotech GAAP EPS of -$0.31 [8/13/2024 8:33 AM] |
1.52 | 0.22 (16.92%) |
0.0 | 0.0 (0.00%) |
0.82 - 2.18 | 349,555 | 90,000 | 0 | ||
| 14-05-2024 | PM | IOBT | IO Biotech, Inc. | 94.00 | -0.30 | -0.37 | 0.00 | IO Biotech GAAP EPS of -$0.30 beats by $0.05 [5/14/2024 12:29 PM] |
1.44 | 0.03 (2.13%) |
1.37 | -0.04 (-2.84%) |
0.82 - 2.28 | 152,720 | 130,000 | 962 | ||
| 05-03-2024 | PM | IOBT | IO Biotech, Inc. | 116.00 | -0.40 | -0.36 | 0.00 | IO Biotech GAAP EPS of -$0.40 misses by $0.02 [3/6/2024 3:39 AM] |
1.66 | 0.04 (2.47%) |
1.62 | 0.0 (0.00%) |
0.82 - 2.68 | 34,731 | 130,000 | 1,221 | ||
| 13-11-2023 | PM | IOBT | IO Biotech, Inc. | 62.00 | -0.43 | -0.47 | 0.00 | IO Biotech GAAP EPS of -$0.43 misses by $0.10 [11/13/2023 1:25 PM] |
0.9502 | 0.02 (2.30%) |
0.89 | -0.04 (-4.47%) |
0.82 - 3.52 | 48,157 | 70,000 | 427 | ||
| 11-05-2023 | AH | IOBT | IO Biotech, Inc. | 59.00 | -0.59 | -0.72 | 0.00 | IO Biotech GAAP EPS of -$0.59 beats by $0.09 [5/11/2023 5:25 PM] |
2.01 | -0.14 (-6.51%) |
0.0 | 0.0 (0.00%) |
1.72 - 7.70 | 60,208 | 20,000 | 0 | ||
| 14-03-2023 | AH | 4:05 PM ET (Mar 14) |
IOBT | IO Biotech, Inc. | 49.00 | -0.69 | -0.57 | 0.00 | IO Biotech GAAP EPS of -$0.69 [3/14/2023 5:36 PM] |
2.25 | -0.19 (-7.79%) |
0.0 | 0.0 (0.00%) |
2.15 - 9.77 | 126,250 | 30,000 | 0 | |
| 09-11-2022 | AH | 5:00 PM ET (Nov 9) |
IOBT | IO Biotech, Inc. | 72.00 | -0.56 | -0.73 | 0.00 | IO Biotech GAAP EPS of -$0.56 in-line [11/9/2022 5:23 PM] |
2.91 | 0.40 (15.94%) |
2.71 | 0.20 (7.97%) |
2.15 - 13.48 | 93,573 | 50,000 | 1,007 | |
|
||||||||||||||||||
| 11-08-2022 | AH | IOBT | IO Biotech, Inc. | 114.00 | -0.64 | -0.65 | 0.00 | IO Biotech GAAP EPS of -$0.64 [8/11/2022 5:23 PM] |
4.05 | 0.12 (3.05%) |
0.0 | 0.0 (0.00%) |
3.50 - 17.88 | 20,026 | 40,000 | 0 | ||
| 16-05-2022 | AH | After the close (May 16) |
IOBT | IO Biotech, Inc. | 191.00 | -0.60 | -0.69 | 0.00 | IO Biotech GAAP EPS of -$0.60 [5/16/2022 5:01 PM] |
6.26 | -0.62 (-9.01%) |
0.0 | 0.0 (0.00%) |
3.56 - 17.88 | 93,898 | 60,000 | 0 | |